Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-05-29 @ 7:02 PM
Study NCT ID:
NCT05552105
Status:
COMPLETED
Last Update Posted:
2025-03-06
First Post:
2022-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA)
Sponsor:
University Hospital, Clermont-Ferrand
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RBHP 2022 TOURNADRE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None